Clinical Trials in Minneapolis

Showing 2721-2740 of 6,957 trials

SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

NCT04054401

The purpose of the study is to evaluate the safety and tolerability of DRG stimulation when placing a neurostimulator during the same procedure as implantation of spinal fixation with or without interbody cage systems in patients with chronic back and/or leg pain requiring single level spinal fusion.

Spinal FusionRadiculopathy LumbarChronic Pain

SynerFuse, Inc20 participantsStarted Jan 2022

Mishawaka, Indiana, United States • Minneapolis, Minnesota, United States

COMPLETEDPhase 3< 1 mile

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

NCT00716976

RATIONALE: Sodium thiosulfate may reduce or prevent hearing loss in young patients receiving cisplatin for cancer. It is not yet known whether sodium thiosulfate is more effective than no additional treatment in preventing hearing loss. PURPOSE: This randomized phase III trial is studying sodium thiosulfate to see how well it works in preventing hearing loss in young patients receiving cisplatin for newly diagnosed germ cell tumor, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma, or other malignancy.

Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more

Children's Oncology Group131 participantsStarted Jun 2008

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +73 more locations

SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Find Trials by Condition in Minneapolis

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Open-label Extension Study of Brazikumab in Ulcerative Colitis

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

Evaluation of VQm PHM on Pulmonary Health Parameters for ICU